Bone Marrow Transplant: Benefits, Risks, and What to Expect

What Is Bone Marrow Transplant (BMT)?

BMT (also called hematopoietic stem cell transplant) replaces diseased or damaged bone marrow with healthy stem cells. It can be autologous (patient's own cells) or allogeneic (donor cells).

Potential Benefits

  • Curative for many hematologic malignancies: Leukemia, lymphoma, multiple myeloma.
  • Corrects non-malignant disorders: Aplastic anemia, sickle cell disease, thalassemia, immunodeficiency syndromes.
  • Restores immune function and hematopoiesis.
  • Long-term remission possible: 5-year survival for acute leukemia with allogeneic BMT ~40–60% (vs. <20% without).

Major Risks & Complications

  • Graft-versus-Host Disease (GVHD): Donor immune cells attack recipient tissues (acute/chronic); major cause of morbidity/mortality in allogeneic BMT.
  • Infections: Bacterial, viral, fungal during prolonged neutropenia and immunosuppression.
  • Organ Toxicity: Veno-occlusive disease (liver), interstitial pneumonitis, cardiac, renal.
  • Infertility from conditioning chemotherapy/radiation.
  • Secondary malignancies years later.
  • Transplant-related mortality (TRM): 10–20% for allogeneic; lower for autologous.

Process Overview

  1. Comprehensive evaluation & donor matching (HLA typing).
  2. Conditioning regimen (chemo ± radiation) to eradicate disease and immunosuppress.
  3. Stem cell infusion (like a blood transfusion).
  4. Engraftment monitoring (neutrophil recovery ~10–28 days).
  5. Extended outpatient follow-up (months to years).

Decision-Making

Requires thorough discussion with transplant team about disease status, donor availability, age, comorbidities, and patient goals. Quality of life during and after transplant is a key consideration.

Kidney Disease - Related Articles